Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


24.10.2016

1 AIDS
2 Ann Intern Med
1 Arch Virol
1 BMJ
1 Clin Infect Dis
1 Dig Dis Sci
3 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
3 J Hepatol
2 J Med Virol
1 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
1 Pediatr Infect Dis J
8 PLoS One
2 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. OLIVER NT, Hartman CM, Kramer JR, Chiao EY, et al
    Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
    AIDS. 2016;30:2469-2476.
    PubMed     Text format     Abstract available


    Ann Intern Med

  2. RABKIN CS, Goedert JJ
    Chronic Hepatitis and Non-Hodgkin Lymphoma Among People With HIV: Implications for Screening, Treatment, and Prevention.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-2340.
    PubMed     Text format    

  3. WANG Q, De Luca A, Smith C, Zangerle R, et al
    Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.
    Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-0240.
    PubMed     Text format     Abstract available


    Arch Virol

  4. ZHANG Z, Zhang Y, Xu N, Huang C, et al
    High risk of occult hepatitis B virus infection in leukemia patients from China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    BMJ

  5. STAFFORD N
    Questions hang over European patent for hepatitis C drug after ruling.
    BMJ. 2016;355:i5493.
    PubMed     Text format    


    Clin Infect Dis

  6. SARRAZIN C, Isakov V, Svarovskaia E, Hedskog C, et al
    Late relapse versus HCV reinfection in patients with sustained virologic response after sofosbuvir-based therapies.
    Clin Infect Dis. 2016.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. BECK KR, Kim N, Khalili M
    Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  8. LI X, Gao F, Liu H, Zhang H, et al
    Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available

  9. TURNER BJ, Liang Y, Singal A
    FIB-4 and imaging for measuring fibrosis in hepatitis C virus.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available

  10. NORDSTROM EM, Keniston A, Baouchi F, Martinez-Camacho A, et al
    Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  11. JUAN JUAN A, Caballero de Garcia N, Masnou Ridaura H, Sala Llinas M, et al
    [Hepatitis B virus reactivation after cessation of prophylaxis with entecavir in a patient with Burkitt type acute lymphoblastic leukaemia treated with rituximab].
    Gastroenterol Hepatol. 2016 Oct 12. pii: S0210-5705(16)30124.
    PubMed     Text format    


    Gastroenterology

  12. LIANG TJ
    Hepatitis C Virus: from Obscurity to the Lasker.
    Gastroenterology. 2016 Oct 17. pii: S0016-5085(16)35233.
    PubMed     Text format    


    Hepatology

  13. PUNZEL M, Medd P, Hunter H, Cunningham R, et al
    Detection of hepatitis b virus DNA in the blood of a stem cell donor after granulocyte colony-stimulating factor treatment.
    Hepatology. 2016;64:1803-1805.
    PubMed     Text format    


    J Hepatol

  14. DEUFFIC-BURBAN S, Boursier J, Leroy V, Yazdanpanah Y, et al
    Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?
    J Hepatol. 2016 Oct 12. pii: S0168-8278(16)30568.
    PubMed     Text format     Abstract available

  15. BEGUELIN C, Moradpour D, Sahli R, Suter-Riniker F, et al
    Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    J Hepatol. 2016 Oct 13. pii: S0168-8278(16)30569.
    PubMed     Text format     Abstract available

  16. XIA Y, Carpentier A, Cheng X, Block PD, et al
    Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
    J Hepatol. 2016 Oct 13. pii: S0168-8278(16)30572.
    PubMed     Text format     Abstract available


    J Med Virol

  17. KATAKI K, Borthakur P, Kumari N, Deka M, et al
    Association of mRNA expression of Toll like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24719.
    PubMed     Text format     Abstract available

  18. KANG SH, Kang K, Yeon JE, Lee YS, et al
    Antiviral response is not sustained after cessation of lamivudine treatment in chronic hepatitis B patients: A 10-year follow-up study.
    J Med Virol. 2016 Oct 21. doi: 10.1002/jmv.24715.
    PubMed     Text format     Abstract available


    J Viral Hepat

  19. LEE S, Ahn SH, Jung KS, Kim DY, et al
    Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    J Viral Hepat. 2016 Oct 20. doi: 10.1111/jvh.12623.
    PubMed     Text format     Abstract available


    MMWR Morb Mortal Wkly Rep

  20. GVINJILIA L, Nasrullah M, Sergeenko D, Tsertsvadze T, et al
    National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016.
    MMWR Morb Mortal Wkly Rep. 2016;65:1132-1135.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  21. ZHU F, Deckx H, Roten R, Michiels B, et al
    Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene(R) TF and Engerix-B(R) Recombinant Hepatitis B Vaccines in Neonates in China.
    Pediatr Infect Dis J. 2016.
    PubMed     Text format     Abstract available


    PLoS One

  22. FLISIAK R, Shiffman M, Arenas J, Cheinquer H, et al
    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
    PLoS One. 2016;11:e0164563.
    PubMed     Text format     Abstract available

  23. ALRIC L, Besson C, Lapidus N, Jeannel J, et al
    Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PLoS One. 2016;11:e0162965.
    PubMed     Text format     Abstract available

  24. HUANG J, Zhao L, Yang P, Chen Z, et al
    Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle.
    PLoS One. 2016;11:e0164787.
    PubMed     Text format     Abstract available

  25. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Correction: Association of Sjogren's Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0164911.
    PubMed     Text format     Abstract available

  26. DE AVILA AI, Gallego I, Soria ME, Gregori J, et al
    Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.
    PLoS One. 2016;11:e0164691.
    PubMed     Text format     Abstract available

  27. WHITE DA, Anderson ES, Pfeil SK, Deering LJ, et al
    Hepatitis C Virus Screening and Emergency Department Length of Stay.
    PLoS One. 2016;11:e0164831.
    PubMed     Text format     Abstract available

  28. GHORI NU, Shafique A, Hayat MQ, Anjum S, et al
    The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population.
    PLoS One. 2016;11:e0164265.
    PubMed     Text format     Abstract available

  29. DAVITKOV P, Chandar AK, Hirsch A, Compan A, et al
    Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
    PLoS One. 2016;11:e0163945.
    PubMed     Text format     Abstract available


    Vaccine

  30. DULAL P, Wright D, Ashfield R, Hill AV, et al
    Potency of a thermostabilised chimpanzee adenovirus Rift Valley fever vaccine in cattle.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30057.
    PubMed     Text format     Abstract available

  31. XEUATVONGSA A, Datta SS, Moturi E, Wannemuehler K, et al
    Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30883.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: